Saba Capital Management, L.P. bought HQL
April 25, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 97,574 shares of Abrdn Life Sciences Investors at $12.99 per share, a transaction worth $1.27M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
97,574
Price
$12.99
Total value
$1.27M
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 25, 2024
Filing dateApril 26, 2024
Shares owned after2,905,298
OwnershipIndirect
10b5-1 planNo
AmendedNo